High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases

Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer

(2018) Min Young Baek et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone onEGFR-mutant non-small cell lung cancer with brain metastasis

(2016) Qiuyi Zhang et al.   Thoracic Cancer

Épidémiologie des lésions métastatiques cérébrales

(2015) S. Taillibert et al.   Cancer Radiotherapie

Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study

(2015) Yisheng Huang et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Definitive Chemoradiation Therapy Following Surgical Resection or Radiosurgery Plus Whole-Brain Radiation Therapy in Non-Small Cell Lung Cancer Patients With Synchronous Solitary Brain Metastasis: A Curative Approach

(2014) Cem Parlak et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

EGFR Mutation and Brain Metastasis in Pulmonary Adenocarcinomas

(2014) Dong-Yeop Shin et al.   Journal of Thoracic Oncology

Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

(2013) Yi-Long Wu et al.   LUNG CANCER

EGFR mutation status and its impact on survival of Chinese non-small cell lung cancer patients with brain metastases

(2013) Dongdong Luo et al.   TUMOR BIOLOGY

Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center

(2012) Jia Jin et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain

(2011) M. Jamal-Hanjani et al.   CLINICAL CANCER RESEARCH

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

(2011) Caicun Zhou et al.   LANCET ONCOLOGY

Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies

(2010) Brunilde Gril et al.   EUROPEAN JOURNAL OF CANCER

Frequency of and variables associated with the EGFR mutation and its subtypes

(2009) Tomoaki Tanaka et al.   INTERNATIONAL JOURNAL OF CANCER

Differential Expression of Biomarkers in Primary Non-small Cell Lung Cancer and Metastatic Sites

(2009) Carlos Gomez-Roca et al.   Journal of Thoracic Oncology

Epidermal growth factor receptor tyrosine kinase inhibitors as a first-line therapy for never-smokers with adenocarcinoma of the lung having asymptomatic synchronous brain metastasis

(2009) Jeong-Eun Kim et al.   LUNG CANCER

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

(2009) Rafael Rosell et al.   NEW ENGLAND JOURNAL OF MEDICINE